Company intelligence / Profile preview
Virogentics
Allen, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ITV-1, a patented immune therapeutic, has shown prior efficacy in HIV/AIDS and is currently undergoing a 60-patient clinical trial in Bulgaria with EMA application ongoing. An African pilot has been completed, and a diabetes pilot is ongoing in Bulgaria. Preclinical work in mAbs platform for infectious diseases targeting multiple viruses.
- Therapeutic areas
- ImmunologyInfectious DiseasesEndocrinologyOncology
- Modalities
- ImmunotherapyMonoclonal antibodyBiologicNutraceutical
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Sagaliam Acquisition Corp (SAGA, business combination/financing)R&D Services Ltd. (Bulgaria, CRO for clinical trials)HEAL Africa Hospitals (DRC, clinical site)Panzi Hospital (DRC, clinical site)University of Pharmacology (Bulgaria, consultants)Kiwi Farma (clinical documentation)Vetprom manufacturing (French concern Danson, manufacturing/GMP)
Beyond the preview
Go deeper on Virogentics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virogentics.